These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19133016)

  • 1. Ventricular assist devices for bridge to myocardial repair.
    Nosé Y
    Artif Organs; 2008 Dec; 32(12):899-902. PubMed ID: 19133016
    [No Abstract]   [Full Text] [Related]  

  • 2. The need to change our objective for artificial heart development: from totally implantable permanent ventricular assist devices to wearable therapeutic ventricular assist devices.
    Nosé Y; Motomura T; Miyamoto H; Ohta K; Takaba J; Sugita Y
    Artif Organs; 2010 Dec; 34(12):1069-76. PubMed ID: 21155845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From apheresis for the preparation of ventricular assist devices and transplantation to combination therapy of apheresis and ventricular assist devices for myocardial repair.
    Nosé Y
    Artif Organs; 2009 Jan; 33(1):1-2. PubMed ID: 19178435
    [No Abstract]   [Full Text] [Related]  

  • 4. Bibliography current world literature.
    Coron Artery Dis; 2008 Nov; 19(7):541-2. PubMed ID: 18923252
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy.
    Anastasiadis K; Antonitsis P; Doumas A; Koliakos G; Argiriadou H; Vaitsopoulou C; Tossios P; Papakonstantinou C; Westaby S
    Int J Cardiol; 2012 Mar; 155(3):e51-3. PubMed ID: 21852003
    [No Abstract]   [Full Text] [Related]  

  • 6. IGF-1 and mechanisms of myocardial repair.
    Penn MS; Agarwal U
    Int J Cardiol; 2010 Jan; 138(1):1-2. PubMed ID: 19535158
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem-cell therapy for ischaemic cardiomyopathy.
    Lad V; Rao V; Badiwala M; Jackman J
    Indian Heart J; 2007; 59(2 Suppl B):B133-42. PubMed ID: 19153429
    [No Abstract]   [Full Text] [Related]  

  • 8. Of mice and men: the best laid scheme?
    Henry TD; Reich HJ; Zeiher AM
    J Am Coll Cardiol; 2015 Apr; 65(14):1435-7. PubMed ID: 25857909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].
    Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and clinical management of cardiomyopathies and heart failure in China.
    Jiang H; Ge J
    Heart; 2009 Nov; 95(21):1727-31. PubMed ID: 19318343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy for heart disease. This exciting field holds promise for repairing damaged hearts.
    Harv Heart Lett; 2012 Dec; 23(4):3. PubMed ID: 23476944
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric application of the Thoratec CentriMag BiVAD as a bridge to heart transplantation.
    Hirata Y; Charette K; Mosca RS; Quaegebeur JM; Chen JM
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1386-7. PubMed ID: 19026842
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathologic findings and their implications in patients managed with temporary ventricular assist.
    Schoen FJ; Palmer DC; Haudenschild CC; Ratliff NB; Watson JT
    Trans Am Soc Artif Intern Organs; 1985; 31():66-72. PubMed ID: 3837528
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on ventricular assist device technology.
    Stahl MA; Richards NM
    AACN Adv Crit Care; 2009; 20(1):26-34; quiz 35-6. PubMed ID: 19174634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Hemodialysis via Arteriovenous Fistula in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Calenda BW; Smietana J; Casagrande L
    Artif Organs; 2016 Jul; 40(7):712. PubMed ID: 27378615
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term, implantable ventricular assist devices: what are they and who needs them?
    Oz MC; Levin HR; Rose EA
    Compr Ther; 1995 Jul; 21(7):351-4. PubMed ID: 7554811
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations.
    Perin EC; Silva GV
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):281-8. PubMed ID: 19213080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular assist device application with the intermediate use of a membrane oxygenator as a bridge to pediatric heart transplantation.
    Garcia-Guereta L; Cabo J; de la Oliva P; Villar MA; Bronte LD; Goldman L; Hübler M
    J Heart Lung Transplant; 2009 Jul; 28(7):740-2. PubMed ID: 19560705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far?
    Mann DL; Willerson JT
    Circulation; 1998 Dec; 98(22):2367-9. PubMed ID: 9832479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.